T0	Participants 16 23	stroke.
T1	Participants 79 95	elderly patients
T2	Participants 325 356	hypertension in older patients.
T3	Participants 357 750	Since 1991, the results of 3 major trials--the British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating older patients (> 60 years) with both diastolic and isolated systolic hypertension.
T4	Participants 1229 1278	treatment of older individuals with hypertension.